J.-P. Azulay

2.8k total citations
40 papers, 2.0k citations indexed

About

J.-P. Azulay is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, J.-P. Azulay has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Psychiatry and Mental health. Recurrent topics in J.-P. Azulay's work include Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (12 papers). J.-P. Azulay is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (21 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (12 papers). J.-P. Azulay collaborates with scholars based in France, Switzerland and Portugal. J.-P. Azulay's co-authors include Jean Pouget, B. Amblard, Tatiana Witjas, Elsa Kaphan, Olivier Blin, Serge Mesure, Marlène Poncet, M. Ceccaldi, A. Ali Chérif and Olivier Blin and has published in prestigious journals such as Brain, Neurology and Neuroscience.

In The Last Decade

J.-P. Azulay

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-P. Azulay France 17 1.6k 427 393 357 260 40 2.0k
Fredy J. Revilla United States 24 1.5k 0.9× 494 1.2× 244 0.6× 269 0.8× 283 1.1× 42 1.8k
Urban M. Fietzek Germany 23 989 0.6× 332 0.8× 234 0.6× 368 1.0× 266 1.0× 67 1.6k
Antonino Cannas Italy 21 894 0.6× 154 0.4× 157 0.4× 254 0.7× 158 0.6× 60 1.2k
David Maltête France 23 1.4k 0.9× 506 1.2× 82 0.2× 206 0.6× 305 1.2× 78 1.8k
S. J. Huber United States 20 1.7k 1.0× 506 1.2× 140 0.4× 347 1.0× 381 1.5× 31 2.2k
Bo Johnels Sweden 23 1.2k 0.7× 546 1.3× 109 0.3× 228 0.6× 278 1.1× 57 1.8k
Janey Prodoehl United States 23 1.3k 0.8× 319 0.7× 195 0.5× 288 0.8× 422 1.6× 48 1.8k
Andrew P. Duker United States 19 928 0.6× 407 1.0× 122 0.3× 217 0.6× 157 0.6× 33 1.2k
Gun‐Marie Hariz Sweden 23 1.2k 0.7× 497 1.2× 140 0.4× 189 0.5× 122 0.5× 41 1.4k
Camila Aquino Brazil 17 751 0.5× 277 0.6× 89 0.2× 215 0.6× 124 0.5× 40 1.0k

Countries citing papers authored by J.-P. Azulay

Since Specialization
Citations

This map shows the geographic impact of J.-P. Azulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Azulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Azulay more than expected).

Fields of papers citing papers by J.-P. Azulay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Azulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Azulay. The network helps show where J.-P. Azulay may publish in the future.

Co-authorship network of co-authors of J.-P. Azulay

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Azulay. A scholar is included among the top collaborators of J.-P. Azulay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Azulay. J.-P. Azulay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castrioto, Anna, Stéphane Thobois, Mathieu Anheim, et al.. (2020). A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD. npj Parkinson s Disease. 6(1). 41–41. 20 indexed citations
2.
Marsot, Amélie, Romain Guilhaumou, J.-P. Azulay, & Olivier Blin. (2017). Levodopa in Parkinson’s Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 20(0). 226–226. 16 indexed citations
3.
Drapier, Sophie, Alexandre Eusébio, Bertrand Degos, et al.. (2016). Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study. Journal of Neurology. 263(6). 1111–1119. 53 indexed citations
4.
Guedj, Eric, Tatiana Witjas, Frédérique Fluchère, et al.. (2014). (18)FDG-PET Scan As A Predictive Marker Of Postoperative Apathy After Subthalamic Nucleus Deep Brain Stimulation In Parkinson Disease. (P2.003). Neurology. 82(10_supplement). 1 indexed citations
5.
Fluchère, Frédérique, Annie Verschueren, Pascal Cintas, et al.. (2010). Clinical features and follow‐up of four new cases of facial‐onset sensory and motor neuronopathy. Muscle & Nerve. 43(1). 136–140. 20 indexed citations
6.
Azulay, J.-P., et al.. (2010). Prise en charge de la crampe de l’écrivain : 14 ans d’expérience de la toxine botulique. Revue Neurologique. 166(6-7). 630–638. 2 indexed citations
7.
Attarian, Shahram, José Boucraut, Alex Hubert, et al.. (2009). Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy. Journal of Neurology Neurosurgery & Psychiatry. 81(1). 61–64. 40 indexed citations
8.
Bénatru, Isabelle, Marianne Vaugoyeau, & J.-P. Azulay. (2008). Postural disorders in Parkinson’s disease. Neurophysiologie Clinique. 38(6). 459–465. 125 indexed citations
9.
Witjas, Tatiana, Elsa Kaphan, Jean Régis, et al.. (2007). Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Movement Disorders. 22(12). 1729–1734. 108 indexed citations
10.
Delmont, Émilien, et al.. (2007). Neuropathies motrices multifocales avec blocs de conduction, profil évolutif sous immunoglobulines intraveineuses. Revue Neurologique. 163(1). 82–88. 7 indexed citations
11.
Vaugoyeau, M., Sébastien Viel, Christine Assaiante, B. Amblard, & J.-P. Azulay. (2007). Impaired vertical postural control and proprioceptive integration deficits in Parkinson’s disease. Neuroscience. 146(2). 852–863. 126 indexed citations
12.
Azulay, J.-P., et al.. (2006). Le syndrome de l’homme raide : formes cliniques, traitement et profil évolutif. Revue Neurologique. 162(8-9). 832–839. 4 indexed citations
14.
Witjas, Tatiana, Christelle Baunez, Marie Delfini, et al.. (2005). Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation. Movement Disorders. 20(8). 1052–1055. 163 indexed citations
16.
Verschueren, Annie, et al.. (2004). Lewis-Sumner syndrome and multifocal motor neuropathy. Muscle & Nerve. 31(1). 88–94. 58 indexed citations
17.
Nguyen, Kien, N. Philip, Laurent Suchet, J.-P. Azulay, & Jean Pouget. (2004). Syndrome oculodentodigital révélé par une paraparésie spastique progressive. Revue Neurologique. 160(1). 83–85.
18.
Escande‐Beillard, Nathalie, Jacques Portoukalian, Jean Pouget, et al.. (2002). A sensitive flow cytometry method for anti-GM1 antibodies detection. Journal of Neuroimmunology. 125(1-2). 163–169. 8 indexed citations
19.
Mesure, Serge, J.-P. Azulay, Jean Pouget, & B. Amblard. (1999). Strategies of segmental stabilization during gait in Parkinson's disease. Experimental Brain Research. 129(4). 573–581. 68 indexed citations
20.
Azulay, J.-P., Serge Mesure, B. Amblard, et al.. (1999). Visual control of locomotion in Parkinson's disease. Brain. 122(1). 111–120. 264 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026